It has become clear that AD with a relatively young age at onset is different from AD observed in the elderly, with neurodegeneration and cognition strongly driven by tau deposition in young patients while contributions of TDP-43 and vascular pathology are important components to disease in older patients. The gene discussed is MAPT; the disease is Alzheimer disease.